chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient says injection was given too high. Patient went to see a doctor for the pain but pain still there.
RASH ALL OVER THE BODY WITH REDNESS NUT NO ITCHING , WAS DESCRIBED BY DAD OVER THE PHONE
Covid arm and measles like rash on my neck and ears. Digestive issues as well.
Patient passed out hours later after Getting shots and her Blood Drawn.   Then Patient Came back into the Clinic with Numbness of fingers and toes. Fatigue and Chills.  We Sent the Patient to the ER.
Pt in for 6 mth well child check today. Mom informed me that he had an episode with decreased tone "floppy", paleness, decreased awareness that lasted for 15- 30 minutes on the date of his last immunizations 06/14/2002. Slight fever present 100.2 degrees.
Today is day three post injection for me and my arm is still swollen, red and slightly itchy at injection site. Tender to touch. My armpit on arm that was injected is very tender and uncomfortable as well.
Arm soreness began last night. This morning I woke up with flu like symptoms, soreness, headache, lethargy, chills.
Pain in my jawbone and then went to the other side and both were in pain. Then the pain accelerated in left shoulder blade in the joint. Within 15 mins, I had pain in all 4 places in jawbones and in shoulder blades. Went home and blood pressure was dangerously high. I tried to sit and remain calm. The pain was unbearable. About 30 mins later, took blood pressure again and blood pressure 175/101. Then center of chest was painful into the neck as well as the pain in jawbone and shoulder blade. I thought he was having a heart attack. My wife drove me to the hospital. I had test ran. Nothing showed up on test. The doctor ask if I had COVID then I stated that I did not. I was admitted for further testing. I was admitted on the COVID floor. I kept stating to the nurse that I did not have COVID. The test took 4 days so had to be admitted until the test came. While during that time, I had more test ran and everything came back good. The pain by then was more bearable and subsided. I did not receive my blood pressure meds while in the hospital. I ask the nurses for my medication. By the end of the 4th day, I was told I would be discharged. My blood pressure was elevated. I was sent home. I called my general doctor, told him my symptoms. My doctor gave me meds for my blood pressure to get it down. The blood pressure eventually went back to normal. I still have pain and can not lay flat in the bed or on my side. I have to elevate myself in the recliner to sleep. The doctor scheduled me an appt for an MRI. By then I was due for my second COVID vaccine. After the second injection within hours, I stated to have a stabbing pain in my stomach. I go back to the doctor and the pain is unbearable. I had  X-rays and an MRI scheduled. On my X-ray, it showed that I had fluid on my lungs. The doctor states it could have been from the vaccine. I was also hospitalized 4 days later. More test was ran, everything came back normal. Once I had the results from MRI, it also showed fluid in my lungs and at the end of my report it states that patients symptoms are due to the COVID vaccine. Was scheduled for another MRI in 30 days. It took about 4 months before pain subsided and I could lay in bed. On the second MRI it showed that the fluid in my lungs has cleared some. I was still short of breath and was told by the doctor that over time this will clear. My doctor and I had agreed not to take the booster. My wife had researched magnification and she put a magnet to my arm and it stuck to my arm.
Within 2-3 minutes felt sensation of throat closing up and difficulty swallowing.  Went to ED within 10 minutes and was treated with EPI, Pepcid, Decadron, Ativan and IV Saline.
Symptoms lasted two to three days after the vaccine. Chills, shivering, sweats, headache, nausea, muscle aches, severe pain and swelling at site of injection, swelling of face, extreme tiredness. Flu like symptoms. Slept two days straight. The injection was on Tuesday afternoon and today is Friday, which is the first time I've been awake and able to drink and eat.
Patient had arm soreness, headache, diarrhea.  Had one blister on arm initially but has spread and now has 5 fluid filled blisters around injection site.
Pt recvd 1st vax of hep B 17NOV89 & exp elevated ALT/AST @ baseline.1st 2 mos of study,pt exp elevated ALT (121-150) & GGT 7FEB90.MD indicated relationship unrelated & review of case indicated chemical hep, B due to HBsAG carriage.
she was limping; couldn't walk good; couldn't lift her leg, couldn't get in the bath tub; bursitis; She was continuing to get worse; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of GAIT DISTURBANCE (she was limping; couldn't walk good) and MOBILITY DECREASED (couldn't lift her leg, couldn't get in the bath tub) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (she was limping; couldn't walk good) (seriousness criterion disability), MOBILITY DECREASED (couldn't lift her leg, couldn't get in the bath tub) (seriousness criterion disability), BURSITIS (bursitis) and CONDITION AGGRAVATED (She was continuing to get worse). The patient was treated with TRAMADOL at a dose of taken 6 in a day; MELOXICAM (MOBIC) at an unspecified dose and frequency; Physical therapy for Gait disturbance; Physical therapy for Mobility decreased and Physical therapy for Bursitis. At the time of the report, GAIT DISTURBANCE (she was limping; couldn't walk good), MOBILITY DECREASED (couldn't lift her leg, couldn't get in the bath tub), BURSITIS (bursitis) and CONDITION AGGRAVATED (She was continuing to get worse) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Magnetic resonance imaging: inconclusive (Inconclusive) They did an MRI which showed no tear; hip joints look fine; doesn't need a hip replacement..         She was also prescribed anti-inflammatory Mobic which she said doesn't help her. No concomitant medications were reported.  Very limited information regarding these events have been provided at this time. No further information is expected.   This case was linked to MOD-2021-168279 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Report content contained no new information.; Sender's Comments: Very limited information regarding these events have been provided at this time. No further information is expected.
UTI: Don't believe my Urinary Tract Infection beginning in August had anything to do with my last Covid-19 vaccination in April
This spontaneous report as received from a non pregnant female nurse of unknown age via a company representative refers to herself. The patient's concurrent conditions and medical history were not reported. On 02-AUG-2016, the patient was subcutaneously vaccinated with ZOSTAVAX (one time injection, dose was not reported, lot # reported as M013377 with expiration date of 25-MAY-2017). The patient was not taking any concomitant medications. In AUGUST 2016, the patient experienced a local reaction, redness and warmth at the injection site and area was "slightly raised 30 millimeters". It was unknown, if the patient was treated for the events. She did not have any laboratory test performed. The patient did not seek any medical attention. The outcome of the events was reported as recovering (also reported that it was unknown if the events improved). Causality assessment was not provided. Additional information has been requested.
Fever; Arm pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and VACCINATION SITE PAIN (Arm pain at injection site) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 014M20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D [VITAMIN D NOS] and SPIRONOLACTONE for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and VACCINATION SITE PAIN (Arm pain at injection site). At the time of the report, PYREXIA (Fever) and VACCINATION SITE PAIN (Arm pain at injection site) outcome was unknown.            No treatment details were reported for the events occurred after specified Dose 2.   This case was linked to MOD-2022-438540 (Patient Link).
Dizzy, light-headed, pale, sweaty. Reclined, observed for 1 hr; discharged ambulatory by physician.
Initial and follow-up information has been received from a physician concerning a 68 year old female patient with hypertension, osteoporosis and DEMEROL allergy and history of chickenpox as a child who on 30-APR-2009 was vaccinated S.Q in her left arm with a dose of ZOSTAVAX (Merck) (lot # 663775/1789X). Concomitant therapy included TENORETIC, BONIVA, Omeprazole (unspecified) and (unspecified). On 01-MAY-2009 the patient experienced a maculo-papular rash with many erythematous lesions distributed on neck and trunk and progressing to the periphery to the proximal extremities. The lesions are itchy and the patient has excoriated the lesions. The patient's maximum temperature was 98.9. The patient has not presented any other systemic symptoms. The physician reported that the patient has not been recently exposed to chickenpox or shingles. On 5-MAY-2009 the patient presented to the office and specimen samples were taken. At the time of reporting the patient was recovering. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the OKA/Merck vaccine VZV strain. Follow-up information has been received from physician concerning the patient. It was reported that the patient developed a rash which looked like early varicella. The physician stated that he was a bit concerned about the rash. It was confirmed that the patient did not experienced shingles since the rash was on both sides of the body. Information has been received from VZV identification program. On 05-MAY-2009 a sample of specimen was taken from scabs of the patient's rash. On 14-MAY-2009 date of PCR analysis was done. The sample was inadequate and no strain was identified. No further information is available.
01/03/22 presents to ED as "Transfer from another hospital. 12 days worsening cough, SOB, rhinorrhea, and weakness". PMHx of "COPD on 3L home O2, PAF on eilquis, and PE"
Terribly itchy rash, with red bumps and welps on sides and buttocks; terribly itchy rash, with red bumps and welps on sides and buttocks; terribly itchy rash, with red bumps and welps on sides and buttocks; This is a spontaneous report from a contactable consumer (patient, self-reported). A 57-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: ER8737 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 07Apr2021 at 10:30 AM, as a single dose for COVID-19 immunization at hospital. The patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6206 and expiry date was not reported), via an unspecified route of administration, in Arm Right, on 10Mar2021 at 10:30 AM, as a single dose for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history included Rheumatoid arthritis (RA) and known allergies: penicillin. Concomitant medications included Enbrel for RA. Since the vaccination, the patient was not tested for COVID-19. The patient reported that on 22Apr2021, she had terribly itchy rash, with red bumps and welps on sides and buttocks. The events were resulted in doctor or other healthcare professional office/clinic visit. The patient received 2 rounds of prednisone and hydroxyzine as treatment for the events. Outcome of the events was not recovered.
Information has been received from a registered nurse concerning an adult dialysis patient between the age of 60-80 years who was vaccinated with a three dose series of Recombivax HB. It was reported that the patient had antibody titer that was less than 10 mIU/ml. A product quality complaint was not involved. Additional information has been requested. This is one of the several reports received from the same source.
I received the 2nd dose of the vaccine on Friday morning. When waking up on Saturday morning, my eyes were itchy, puffy, and my face had hives with small, white bumps. The hives are mainly on my eyelids, cheeks, and my upper lip.
Patient had allergic reaction to covid-19 vaccine (Pfizer) since the booster shot (12/13/21). She had 20-30 inflammatory vesicles and bullae at the left arm with rash. She also reported mild pain. I gave her Claritin 10 MG Oral Tablet  and Halobetasol Propionate 0.05 % External Ointment  today. Waiting for outcome.
Narrative:  Pt was an 84 YO male with PMH of debility, dementia, dysphagia, BPH, and HTN who presented to the ER for cough productive with white/yellow sputum. Pt was diagnosed with aspiration pneumonia. On 11/02/21, an express team was called d/t increased soa and hypoxia. MICU team discussed transfer to step down unit with patient, however he declined transfer and requested comfort focused care.
nauseousness; vomiting; gastro intestinal issues; diarrhea; This spontaneous case was reported by a health care professional and describes the occurrence of GASTROINTESTINAL DISORDER (gastro intestinal issues), DIARRHOEA (diarrhea), NAUSEA (nauseousness) and VOMITING (vomiting) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced GASTROINTESTINAL DISORDER (gastro intestinal issues) and DIARRHOEA (diarrhea). On 05-Apr-2021, the patient experienced NAUSEA (nauseousness) and VOMITING (vomiting). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency and SODIUM ALGINATE (GAVISCON ADVANCE [SODIUM ALGINATE]) at an unspecified dose and frequency. On 05-Apr-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, GASTROINTESTINAL DISORDER (gastro intestinal issues), NAUSEA (nauseousness) and VOMITING (vomiting) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient has underlying disabilities medical condition.  There is no concomitant list provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up received on 27-may-2021. no new information received
Both patient and spouse we given their Moderna prime dose on 2-10-21. Both patient and spouse agreed to observe the post vaccination waiting period and reported no concerns.  On 3-10-2021, they returned for their boost dose at 12:30 PM.  Prior to administration of their second dose,  they reported only mild headache and fatigue that presented approximately 12 hours after their  first dose was administered.   Once again, spouse and patient observed the post vaccination waiting period and reported no issues.  On 3-11-21,  I was notified that patient had passed away at home.  In speaking to spouse, he stated that they both went to bed that evening with with a mild headache and fatigue. Spouse stated that he woke up early that morning with a more pronounced headache and had difficulty sleeping.  He noted that at approximately 5:18 AM  patient seemed to breathing heavily and may have gasped a bit.  He checked on her again around 6:40 and determined that she had passed away.  He contacted EMS and the technician confirmed that she had passed away.  Spouse reports that the state will perform and autopsy in the next few days at the direction of Medical staff.
Patient was receiving MMR and Varicella and the medical assistant administered ProQuad instead of each vaccine separately.  ProQuad is not recommended for this age group.  Patient has not reported any adverse effects from the combination vaccine but was recommended that this report be placed.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. There was no information regarding the patients' pertinent medical history, drug reactions, allergies or concomitant therapies provided. On unknown dates, the patients were vaccinated with doses of PROQUAD (lot #, expiration date, site, dose and route of administration were not reported). The nurse stated that all patients has pain at the injection site when PROQUAD was administered. The outcome of the event was unknown. The relatedness between the event and PROQUAD was not reported. This is one of two reports received from the same source. Additional information has been requested.
12/13/22 presents to ED for "tachycardia". PMHx of "CLL, history of breast cancer s/p mastectomy"
This spontaneous report has been received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient had not pertinent medical history and there were no drug allergies/drug reactions reported. On an unknown date, the patient was vaccinated with (Merck) VARIVAX, (Lot number, expiration date, dose and strength were not reported), route default as subcutaneous. No concomitant medication was reported. The reporter stated, that the patient was vaccinated with the (Merck) VARIVAX, which had been subject to defrost cycling. No adverse event was reported. Additional information has been requested.
I was sitting there eating with family and all of a sudden felt like I was going to tip over out of my seat. I lost sense of up and down for approximately 15 seconds.; I have been struck with 3 bouts of what I think are vertigo.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 35-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at age of 35 years via an unspecified route of administration, administered in Arm Left on 16May2021 09:30 (Lot Number: EW0185) as single dose, dose 2 via an unspecified route of administration, administered in Arm Left at age of 35 years on 06Jun2021 16:30 (Lot Number: EW0217) as single dose for covid-19 immunisation. Medical history included semi-rough bout of covid in early Dec2020. The patient's concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No any other medications the patient received within 2 weeks of vaccination. Between the time of the first shot (since May2021) and post-second shot (most recent event was at breakfast on 13Jun2021), patient had been struck with 3 bouts of what he thought was vertigo. Have not had that issue before. Patient didn't have allergies. The worst of them was that morning at breakfast, Patient was sitting there eating with family and all of a sudden felt like he was going to tip over out of my seat. He lost sense of up and down for approximately 15 seconds. Had this happened while he was driving not sure what may have occurred. No treatment received. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered in Jun2021.  Information on Lot/Batch number was available. Additional information has been requested.
Chills, sweats, nausea, muscle aches, fatigue and site soreness.
Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007D21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ROSUVASTATIN and VITAMINS NOS for an unknown indication.    On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jul-2021, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No treatment information was reported.  The patient had an appointment on the 24th with PCP, to discuss the recommendation she was given to take J&J's vaccine as a second dose. She was hesitant of taking it while still having symptoms.
HEADACHE, BODY ACHES,  INJECTION SITE RED, WARM, 7CM WHEEL, RAISED RASH ON FOREHEAD & HEAD ON DAY 3 & 4, DAY 5 HEADACHE & RASH REMAINS THE SAME WITH A NEW AREA ARISING.  REDNESS TO ARM DECREASED, AREA HARD TO TOUCH.  DAY 6 REMAINS THE SAME
Extraneous dose, not realized until entered in database, had a Janssen 03/17/2021. On consent form ct denied ever having a COVID vaccine previously. Attempted to call ct twice to assess how he did, no answer, unable to leave a message.
This spontaneous reprot was received from a health professional (nurse) refers to multiple unspecified patients of unknown demographics. Relevant medical history, concurrent conditions and drug reactions/allergies of these patients were unspecified. On an unspecified date, the patients were vaccinated with improperly stored M-M-R II (incorrect product storage). Concomitant medications were not reported. No adverse effects were reported. This is one of the four reports received from the same reporter. Additional information has been requested.